SMTL ID : 9ix2.1

Crystal structure of the mouse RIP3 kinase domain in complexed with TAK-632

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

homo-dimer

Ligands

1 x 1SU: N-{7-cyano-6-[4-fluoro-3-({[3-(trifluoromethyl)phenyl]acetyl}amino)phenoxy]-1,3-benzothiazol-2-yl}cyclopropanecarboxamide(Non-covalent)

1SU.1: 22 residues within 4Å: Chain A: V.36, A.49, K.51, M.65, L.68, V.73, L.74, L.93, T.95, R.96, F.97, M.98, E.99, G.101, L.132, L.139, H.141, L.150, L.159, A.160, D.161, F.162 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.49, A:K.51, A:L.68, A:V.73, A:L.74, A:T.95, A:F.97, A:L.150 Hydrogen bonds: A:K.51, A:M.98, A:M.98, A:D.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Su, H. et al., Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro. Nat Commun (2025)

Release Date

2025-05-07

Peptides

Receptor-interacting serine/threonine-protein kinase 3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Receptor-interacting serine/threonine-protein kinase 3

Related Entries With Identical Sequence